Annals of Oncology

Upload Records Snowball Search Search OpenAlex

About the database

On this page:Overview Key papers

ScholarIQanswers from OpenAlex

JournalCitation impact & published research

67,745

Works

1,131,788

Citations

386

h-index

4,060

APC (USD)

IDs:OpenAlex

What are the most-cited papers on Annals of Oncology?

ScholarIQmost cited works

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Roberto Salgado, Carsten Denkert, Sandra Demaria, Nicolas Sirtaine, Frederick Klauschen, Giancarlo Pruneri, Stephan Wienert, Gert Van den Eynden, Frederick L. Baehner, Frédérique Penault‐Llorca, Edith A. Perez, E. Aubrey Thompson, W. Fraser Symmans, Andrea L. Richardson, Jane Brock, Carmen Criscitiello, Helen D. Bailey, M. Ignatiadis, Giuseppe Floris, Joseph A. Sparano, Zuzana Kos, Torsten O. Nielsen, David L. Rimm, Kimberly H. Allison, Jorge S. Reis‐Filho, Sibylle Loibl, Christos Sotiriou, Giuseppe Viale, Sunil Badve, Sylvia Adams, Karen Willard‐Gallo, Sherene Loi

Annals of Oncology. 20143,167 CitationsOPEN ACCESS

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

Timothy A. Chan, Mark Yarchoan, Elizabeth M. Jaffee, Charles Swanton, Sergio A. Quezada, Albrecht Stenzinger, Solange Peters

Annals of Oncology. 20182,907 CitationsOPEN ACCESS

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

John B.A.G. Haanen, Franck Carbonnel, Caroline Robert, Keith M. Kerr, Solange Peters, James Larkin, Karin Jordan

Annals of Oncology. 20172,358 CitationsOPEN ACCESS

Related on ScholarIQ

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Paper

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

Paper